We further performed in-silico analysis of breast cancer patient data from the Cancer Genome Atlas (TCGA) and established that the FRK proximal promoter region in tumors samples had a lower methylation density compared with the matched normal tissues (Supplementary Table 8 and Supplementary Figure 8A, 8B) [49]. The gene discussed is FRK; the disease is breast carcinoma.